Hosted on MSN11mon
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant DepressionSee: Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development BPL-003 is a synthetic and patent-protected benzoate salt formulation of 5-MeO-DMT (aka mebufotenin) designed ...
Some researchers believe DMT, a powerful psychedelic that may naturally occur in the brain, could be your soul’s “ferryman.” ...
Hosted on MSN11mon
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's InfluencePartners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have jointly announced positive initial results from a Phase 2a study of Beckley’s novel formulation of 5-MeO-DMT in Treatment ...
Guggenheim initiated coverage of GH Research (GHRS) with a Buy rating and $32 price target The firm’s thesis on GH is based around the belief ...
or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results